The Global 3D Bioprinting Market is projected to grow at a CAGR of around 16% during the forecast period, i.e., 2023-28. The growth of the market is likely to be driven mainly by limited number of organ donors worldwide, which has instigated research organizations to develop complete organs inside laboratory setups, i.e., only possible through 3D bioprinting. Further, the mounting prevalence of kidney diseases, especially across North America & Asia-Pacific, is generating the need for kidney transplantation in case of a failure, thereby augmenting the demand for the development & fabrication of complex tissues & organs for replacement purposes.
Global 3D Bioprinting Market Research Report: Forecast (2023-2028)